http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107432929-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107432929-B |
| titleOfInvention | Animal composite immunopotentiator and application thereof, and method for determining optimal component content of immunopotentiator |
| abstract | The invention discloses an animal composite immunopotentiator, an application thereof and a method for determining the optimal component content of the immunopotentiator, wherein the animal composite immunopotentiator is prepared from the following raw materials in parts by weight: 20-80 parts of astragalus polysaccharide, 10-60 parts of concanavalin and 7.5-30 parts of levamisole hydrochloride. The application of the animal composite immunopotentiator in preparing the medicament for preventing animal viral diseases is that the components in the formula are as follows: canavalid: astragalus polysaccharide = 3: 1: 2, dissolving in 0.9 percent of physiological saline, and fully and uniformly mixing to prepare the injection with the concentration of 600 mg/ml; the injection has a dose of 60 mg/kg/day, and can be continuously injected for three days, and injected into abdominal cavity or muscle to prevent animal viral diseases. The animal composite immunopotentiator has the advantages of high safety, high efficiency, multiple functions and low production cost. |
| priorityDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 165.